HyProCure® is Scientifically Proven to Eliminate Excessive Joint Forces within the Foot

Oct. 18, 2011 - PRLog -- Minimally Invasive Foot Implant by GraMedica^® Offers Innovative Treatment Option for Faulty Foot Mechanics

(MACOMB, MICHIGAN) July 22, 2011 -- GraMedica^®, a global orthopedic medical device company, provides a revolutionary internal talotarsal stabilization device that is placed inside the foot via a minimally invasive out-patient procedure. The effects of talotarsal dislocation include fallen arches, bunions, overpronation, Achilles tendonitis, posterior tibial tendon dysfunction, and pain in the foot, ankle, knee, hip, back or even shoulder and jaw area. The HyProCure^® device instantly stabilizes the ankle bone on the hindfoot bones, leading to reversal of the associated effects of the dislocation. HyProCure^® represents a real solution for patients suffering from this condition (http://www.gramedica.com/gramedica/resources/presentations/hyprocure-talotarsal-stabilization/). HyProCure^® has been used by foot surgeons since 2004.

The findings of a recent study on the HyProCure^® talotarsal fixation device have been published in the Journal of the American Podiatric Medical Association (JAPMA Vol. 101(5) (2011) 390-399). The purpose of this research, “Stabilization of Joint Forces of the Subtalar Complex via HyProCure Sinus Tarsi Stent,” was to measure the effectiveness of HyProCure^® in stabilizing the subtalar joint complex and eliminating the excessive abnormal forces acting on the foot. The data for the study was collected through a cadaver analysis by Dr. Michael E. Graham, podiatric surgeon and inventor of the HyProCure^® device and Vijal Goel, PhD, Co-Director, Engineering Center for Orthopaedic Research Excellence (E-CORE), and Professor, Departments of Bioengineering and Orthopaedic Surgery, Colleges of Engineering and Medicine, University of Toledo.

“Instability of the hindfoot bones leads to excessive abnormal forces acting on the ligaments and tendons on the inner-side of the foot,” said Graham. “What we found was that instead of the redirection of forces from the ankle bone going through the back of the heel they were being forced to the front of the foot. The ligaments and tendons then have to deal with these extra-forces that occur with every step taken and eventually become strained. Once we placed HyProCure^® into the foot and stabilized the ankle bone, we re-measured the forces and found they were restored back to normal.” Where external measures such as arch supports remain questionable in offering a cure, internally placed HyProCure^® has now provided that evidence.

HyProCure^® effectively improves the alignment of the hindfoot bones. With the insertion of the stent, the joints were no longer dislocating and the forces were brought back to normal.

Foot and ankle surgeons are invited to learn more about the HyProCure^® implant and procedure at http://www.hyprocuredoctors.com, where they can also train online and/or find a live surgical training seminar in their area.

Learn more about HyProCure^® and osteo-WEDGE™, GraMedica^®’s latest innovative Bone Locking System at www.gramedica.com; follow updates on http://www.Facebook.com/HyProCure.

About GraMedica:
GraMedica^® is a global orthopedic medical device company and leader in foot care solutions. Recognized for its innovation, the company is producer of breakthrough products like HyProCure^® and osteo-WEDGE™.

Contacts:
Susan Doherty, Director, Education & Physician Resources
+1-586-677-9600
sdoherty@grahamiii.com

# # #

GraMedica® is a global orthopedic medical device company and leader in foot care solutions. Our products are developed to correct the root problem, not merely treat the symptoms. All products are developed by surgeons with years of experience.